Nolph K D
Perit Dial Int. 1996 Jan-Feb;16(1):15-8.
The relative risks of death for CAPD and HD reported in the literature and at recent meetings most likely reflect case-mix differences and varying percentages of adequately dialyzed patients within the compared populations. A prospective randomized comparison of CAPD and HD patients will be unlikely because of the expense. Therefore, we should attempt to improve the way that both CAPD and HD are practiced. There is no conclusive evidence that the choice of CAPD or HD per se yields a specific modality advantage for survival.
文献及近期会议中报道的持续性非卧床腹膜透析（CAPD）和血液透析（HD）的相对死亡风险，很可能反映了病例组合的差异以及在比较人群中充分透析患者的不同比例。由于费用问题，不太可能对CAPD和HD患者进行前瞻性随机对照研究。因此，我们应尝试改进CAPD和HD的实施方式。没有确凿证据表明选择CAPD或HD本身会在生存方面产生特定的模式优势。
